• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝移植中的锝标记去唾液酸糖蛋白受体显像:初步临床经验

Tc-NGA imaging in liver transplantation: preliminary clinical experience.

作者信息

Woodle E S, Ward R E, Stadalnik R C, Vera D R

机构信息

Department of Surgery, University of California, Davis Medical Center, Sacramento 95817.

出版信息

Surgery. 1989 Mar;105(3):401-7.

PMID:2646744
Abstract

Technetium-99m galactosyl-neoglycoalbumin (Tc-NGA) is a new liver imaging agent that binds to hepatic-binding protein, a hepatocyte-specific membrane receptor. The purpose of this study was to determine the potential of Tc-NGA imaging in clinical liver transplantation. A total of 25 studies were performed in nine patients. Imaging studies performed in the early posttransplant period in patients with good hepatic allograft function revealed diffuse patchiness in tracer distribution, a manifestation of preservation damage. Left lobar infarction was demonstrated within a few hours of ischemic injury. Right posterior segmental infarction was seen in another patient. Comparison of kinetic, clinical, and biochemical data revealed good correlation between hepatic allograft function and Tc-NGA kinetics. Major kinetic alterations were noted during periods of preservation injury, hepatic infarction, and acute rejection. These studies indicate: (1) major alterations in Tc-NGA kinetics occur during preservation injury, hepatic infarction, and acute rejection, and (2) Tc-NGA kinetic data appear to provide an accurate reflection of hepatic allograft function. Tc-NGA imaging has the advantages of being noninvasive and of utilizing standard nuclear medicine instrumentation, including portable imaging devices. In conclusion, Tc-NGA imaging provides a promising noninvasive approach for evaluation of liver function in patients undergoing hepatic transplantation.

摘要

锝-99m半乳糖基-新糖白蛋白(Tc-NGA)是一种新型肝脏显像剂,它能与肝结合蛋白(一种肝细胞特异性膜受体)相结合。本研究的目的是确定Tc-NGA显像在临床肝移植中的应用潜力。对9例患者共进行了25项研究。对移植后早期肝功能良好的患者进行的显像研究显示,示踪剂分布呈弥漫性斑片状,这是保存损伤的表现。缺血损伤后数小时内发现左叶梗死。另一例患者可见右后段梗死。动力学、临床和生化数据的比较显示,肝移植功能与Tc-NGA动力学之间具有良好的相关性。在保存损伤、肝梗死和急性排斥反应期间,观察到主要的动力学改变。这些研究表明:(1)在保存损伤、肝梗死和急性排斥反应期间,Tc-NGA动力学发生重大改变;(2)Tc-NGA动力学数据似乎能准确反映肝移植功能。Tc-NGA显像具有无创性以及可使用包括便携式成像设备在内的标准核医学仪器的优点。总之,Tc-NGA显像为评估肝移植患者的肝功能提供了一种很有前景的无创方法。

相似文献

1
Tc-NGA imaging in liver transplantation: preliminary clinical experience.肝移植中的锝标记去唾液酸糖蛋白受体显像:初步临床经验
Surgery. 1989 Mar;105(3):401-7.
2
Tc-NGA imaging in liver transplantation: preclinical studies.锝标记的N-乙酰半胱氨酸(Tc-NGA)肝脏移植成像:临床前研究
Surgery. 1987 Jul;102(1):55-62.
3
Technetium-99m NGA functional hepatic imaging: preliminary clinical experience.锝-99m NGA 功能性肝脏显像:初步临床经验。
J Nucl Med. 1985 Nov;26(11):1233-42.
4
Tc-99m galactosyl-neoglycoalbumin hepatic scintigraphy in fulminant hepatic failure.锝-99m半乳糖基新糖白蛋白肝脏闪烁扫描术在暴发性肝衰竭中的应用
Clin Nucl Med. 1995 Apr;20(4):329-33. doi: 10.1097/00003072-199504000-00009.
5
Kinetic sensitivity of a receptor-binding radiopharmaceutical: technetium-99m galactosyl-neoglycoalbumin.一种受体结合放射性药物的动力学敏感性:锝-99m半乳糖基新糖白蛋白
J Nucl Med. 1989 Sep;30(9):1519-30.
6
Synthesis and biological evaluation of (99m)Tc-DMP-NGA as a novel hepatic asialoglycoprotein receptor imaging agent.新型肝去唾液酸糖蛋白受体显像剂(99m)Tc-DMP-NGA的合成与生物学评价
Appl Radiat Isot. 2010 Jan;68(1):105-9. doi: 10.1016/j.apradiso.2009.09.015. Epub 2009 Sep 15.
7
Tc-99m-galactosyl-neoglycoalbumin: in vivo characterization of receptor-mediated binding to hepatocytes.锝-99m-半乳糖基-新糖白蛋白:受体介导与肝细胞结合的体内特性研究
Radiology. 1984 Apr;151(1):191-6. doi: 10.1148/radiology.151.1.6701314.
8
[Galactosyl neoglycoalbumin:preparation and studies of its binding with hepatic special receptor].[半乳糖基新糖白蛋白:其与肝脏特异性受体结合的制备与研究]
Hua Xi Yi Ke Da Xue Xue Bao. 1991 Sep;22(4):368-71.
9
Validation of in vivo receptor measurements via in vitro radioassay: technetium-99m-galactosyl-neoglycoalbumin as prototype model.通过体外放射分析验证体内受体测量:锝-99m-半乳糖基新糖白蛋白作为原型模型
J Nucl Med. 1991 Jun;32(6):1177-82.
10
Quantification of human hepatic binding protein (HBP) via 99mTc-galactosyl-neoglycoalbumin (NGA) liver scintigraphy.通过99mTc-半乳糖基新糖白蛋白(NGA)肝脏闪烁扫描术对人肝结合蛋白(HBP)进行定量分析。
Wien Klin Wochenschr. 1991;103(15):458-61.